Network Pharmacology Study of Action Mechanism of Traditional Chinese Medicine in The Treatment Of COVID-19
DOI:
https://doi.org/10.54097/5edjj687Keywords:
COVID-19; SARS-CoV-2; traditional Chinese medicine; network pharmacology.Abstract
Big data was utilized to analyze the network of biological systems and multi-target drug signal nodes, and despite traditional Chinese medicine proving effective against COVID-19 since the 2019 outbreak, the complexity and challenging actions of network pharmacology are essential for in-depth analysis. Objective: To present an overview of the literature on the mechanism of traditional Chinese medicine (TCM) in the treatment of COVID-19 based on network pharmacology. Methods: A succinct explanation of the data sources: Twenty items in all were found after browsing the English and Chinese data websites. Following screening, data synthesis techniques and the remaining eight publications were located. Results: This study contained eight publications, including network pharmacology investigations on the mechanisms of action of eight prescription TCM medications. Many prescription drugs and specialty treatments from traditional Chinese medicine, including astragalus membranaceus-atractylodes rhizoma, LHQW, TJQWG, ephedra and glycyrrhiza, Yinqiao powder, rhizoma polygonati, MXSGD, and HSBDF, have been utilized in the clinical treatment of COVID-19. Their primary modes of action entail several components working on many targets and pathways related to immune modulation, organ protection, antiviral, and anti-inflammatory properties. Conclusion: This study reviewed eight Chinese herbal formulas used for treating COVID-19 and found they all contain quercetin, a compound that may reduce lung damage, and target at least one of TNF, IL-2, or IL-6, potentially decreasing inflammation and boosting immunity. All these traditional Chinese medicine (TCM) treatments were effective against COVID-19, offering valuable insights and inspiration for future drug research.
Downloads
References
Coronavirus disease (covid-19) pandemic. (n.d.). Retrieved from https://www.who.int/europe/emergencies/situations/covid-19
World Health Organization 2023 data.who.int, WHO Coronavirus (COVID-19) dashboard > Data [Dashboard]. https://data.who.int/dashboards/covid19/data
C. Huang et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223).
X. Sun and K. Wei. Network pharmacological analysis of effective components of traditional Chinese medicine in treatment of Novel coronavirus infection. Chinese Journal of Pathogen Biology(Chinese), 2024, 19(3): 371-373.
W. Tu, J. Zhu, M. Li, M. Chen, C. Yang and H. Gan. Based on the network pharmacological research on the mechanism of Huangqi and Baizhu in the treatment of COVID-19. Fujian Traditional Chinese Medicine(Chinese), 2021, 52(2): 1-5.
A. L. Hopkins. Network pharmacology. Nat Biotechnol, 2007, 25(10): 1110-1111.
S. I. Berger and R. Iyengar. Network analyses in systems pharmacology. Bioinformatics, 2009, 25(19): 2466-2472.
B. Zhang, X. Wang, and S. Li. An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin. Evid Based Complement Alternat Med, 2013, 2013: 456747.
W. U. Jiashuo, Z. Fangqing, L. I. Zhuangzhuang, J. Weiyi, and S. Yue. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review. J Tradit Chin Med, 2022, 42(3): 479-486.
S. Li and B. Zhang. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med, 2013, 11(2): 110-120.
X. Zhang et al.. A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19. Int J Med Sci, 2021, 18(8): 1866-1876.
B.-Y. Yang et al.. A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19). Curr Med Sci, 2021, 41(2): 297-305.
X. Li et al.. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19). Aging (Albany NY), 2021, 13(4): 4811-4830.
H. Lin et al.. Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology. Phytother Res, 2021, 35(5): 2651-2664.
C. Mu, Y. Sheng, Q. Wang, A. Amin, X. Li, and Y. Xie. Potential compound from herbal food of Rhizoma Polygonati for treatment of COVID-19 analyzed by network pharmacology: Viral and cancer signaling mechanisms. J Funct Foods, 2021, 77:104149.
Y. Li et al.. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification. J Ethnopharmacol, 2021, 271: 113854.
Y. Cai, M. Zeng, and Y.-Z. Chen. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking. Ann Palliat Med, 2021, 10(4): 3864-3895.
S. F. Pedersen and Y.-C. Ho. SARS-CoV-2: a storm is raging. J Clin Invest, 2020, 130(5): 2202-2205.
W.-Y. Lai, J.-W. Wang, B.-T. Huang, E. P.-Y. Lin, and P.-C. Yang. A Novel TNF-α-Targeting Aptamer for TNF-α-Mediated Acute Lung Injury and Acute Liver Failure. Theranostics, 2019, 9(6):1741-1751.
T. Tanaka, M. Narazaki, and T. Kishimoto. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy, 2016, 8(8): 959-970.
B. Fu, X. Xu, and H. Wei. Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med, 2020, 18(1): 164.
Y. Zhou et al.. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev, 2020, 7(6): 998-1002.
Z. Xu et al.. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020, 8(4): 420-422.
S. Tian, W. Hu, L. Niu, H. Liu, H. Xu, and S.-Y. Xiao. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol, 2020, 15(5): 700-704.
S.-C. Cheng, W.-C. Huang, J.-H. S Pang, Y.-H. Wu, and C.-Y. Cheng. Quercetin Inhibits the Production of IL-1β-Induced Inflammatory Cytokines and Chemokines in ARPE-19 Cells via the MAPK and NF-κB Signaling Pathways. Int J Mol Sci, 2019, 20(2):2957.
A. B. Granado-Serrano, M. Á. Martín, L. Bravo, L. Goya, and S. Ramos. Quercetin attenuates TNF-induced inflammation in hepatic cells by inhibiting the NF-κB pathway. Nutr Cancer, 2012, 64(4): 588-598.
W. Ngwa et al.. Potential of Flavonoid-Inspired Phytomedicines against COVID-19. Molecules, 2020, 25(11): 2707.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
